Petros Pharmaceuticals Correlations
| PTPI Stock | USD 0.29 0.02 7.41% |
The current 90-days correlation between Petros Pharmaceuticals and HCW Biologics is -0.02 (i.e., Good diversification). The correlation of Petros Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Petros Pharmaceuticals Correlation With Market
Good diversification
The correlation between Petros Pharmaceuticals and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Petros Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Petros |
Moving together with Petros Stock
| 0.61 | EQ | Equillium | PairCorr |
| 0.63 | ME | 23Andme Holding | PairCorr |
| 0.68 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.75 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.78 | TCHH | Trustcash Holdings | PairCorr |
| 0.67 | TLK | Telkom Indonesia Tbk | PairCorr |
Moving against Petros Stock
| 0.62 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.61 | RNXT | RenovoRx | PairCorr |
| 0.71 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.69 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.68 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.53 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.48 | HPQ | HP Inc | PairCorr |
| 0.46 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.42 | T | ATT Inc Sell-off Trend | PairCorr |
| 0.37 | HD | Home Depot | PairCorr |
Related Correlations Analysis
| -0.02 | 0.86 | -0.55 | 0.8 | -0.68 | ELYM | ||
| -0.02 | -0.17 | 0.1 | 0.11 | -0.01 | HCWB | ||
| 0.86 | -0.17 | -0.54 | 0.7 | -0.58 | SCPH | ||
| -0.55 | 0.1 | -0.54 | -0.39 | 0.51 | MIST | ||
| 0.8 | 0.11 | 0.7 | -0.39 | -0.63 | MCRB | ||
| -0.68 | -0.01 | -0.58 | 0.51 | -0.63 | LUMO | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Petros Stock performing well and Petros Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Petros Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ELYM | 3.92 | (0.78) | 0.00 | 0.73 | 0.00 | 6.21 | 34.87 | |||
| HCWB | 13.20 | 4.04 | 0.35 | (1.01) | 8.16 | 22.00 | 352.85 | |||
| SCPH | 2.64 | (0.84) | 0.00 | (0.35) | 0.00 | 4.05 | 20.70 | |||
| MIST | 1.90 | 0.19 | 0.12 | 0.24 | 1.61 | 7.19 | 18.66 | |||
| MCRB | 4.93 | 0.19 | 0.02 | 0.60 | 5.66 | 10.84 | 28.84 | |||
| LUMO | 2.44 | 0.38 | 0.06 | (0.43) | 2.72 | 5.95 | 16.25 |
Petros Pharmaceuticals Corporate Management
| Mitchell MBA | VP Officer | Profile | |
| Keith Lavan | Advisor | Profile | |
| John Shulman | Executive Board | Profile | |
| Robert Weinstein | Interim Officer | Profile |